Using clinical-led AI, Truveta expands clinical notes and medical images available to advance research
From detailed family history and complex concepts from a wide range of therapeutic areas to millions of de-identified medical images, Truveta empowers researchers with the most…
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
BELLEVUE, Wash. – April 25, 2024 – Truveta, the company with a mission of Saving Lives with Data, announced today the largest and most complete mother-child…
CDC awards Truveta a real-world data contract to study COVID, maternal health, and pediatric care
BELLEVUE, Wash. – January 22, 2024 – Today, Truveta, a growing collective of 30 health systems with a shared mission of Saving Lives with Data, was…
Truveta Research on increased speech delays in children during the pandemic published in JAMA Pediatrics
In a study of more than 2.4 million children under the age of 5, new research shows a significant increase in the rate of first-time speech…
Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors
BELLEVUE, Wash. – December 4, 2023 – Truveta, the company with a mission of saving lives with data, welcomes its first member from the life science…
Largest real-world data study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
In the first comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data, Truveta Research found that patients with overweight or…
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research
More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study safety and effectiveness, improve patient care, and train medical AI
BELLEVUE, Wash. – October 23, 2023 – Truveta announced today that it is partnering with more than 50 organizations in life sciences, healthcare, government, academic medical…
Truveta advances security and privacy with Type 2 SOC 2 examination
Truveta has completed its Type 2 SOC 2 examination and continue to maintain ISO 27001 certifications, demonstrating the company’s relentless commitment to security, privacy, and trust.…
Partnership news: Truveta and Mathematica to advance public health and health equity with real-world data
Powerful partnership will allow researchers access to the most complete, timely, and clean health data to improve outcomes BELLEVUE, Wash. and PRINCETON, New Jersey – September…
Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease
Truveta Data will enable Medical Components, Inc. to study manufacturer-specific medical device data to address medical evidence gaps and improve clinical care recommendations. BELLEVUE, Wash. –…
Truveta Data now includes medication dispense data to help address nation’s 7th leading cause of death
With new medication dispense data – including prescription fill data from specialty pharmacies – Truveta Data offers even more complete, timely, and clean data to study…
Truveta community expands to more than 40 healthcare and life science organizations with a shared mission of saving lives with data
BELLEVUE, Wash. – May 17, 2023 – Today Truveta, a leader in electronic health record (EHR) data and analytics, announces the expansion of its community to…
JAMA Network Open publishes Truveta and Harvard University collaboration
New research published in JAMA Network Open shows changes in minoxidil prescribing following media attention about oral use for hair loss. BELLEVUE, Wash. – May 11,…
Truveta Language Model unlocks EHR data for the most complete and accurate medical research
Truveta’s clinical expert-led AI delivers the cleanest healthcare data, including structured concepts from clinician notes BELLEVUE, Wash. – April 12, 2023 – Today Truveta introduces the…
Truveta and Alpine Immune Sciences announce strategic partnership to access Truveta’s community to accelerate recruitment to povetacicept clinical trials
Truveta’s 28 health system members provide over 16% of patient care in the United States. BELLEVUE and SEATTLE, Wash. – March 21, 2023 – Today, Truveta…
New SDOH data in Truveta Studio provide most complete view of health equity’s influence on patient health and outcomes
Expanded de-identified social drivers of health data in Truveta Studio empower new health equity scenarios to study health disparities and improve patient care. BELLEVUE, Wash. –…
Truveta’s COVID-19 breakthrough infections research published in Vaccine
In a study of more than 1.2 million patients, new research shows the interaction effects of multiple comorbidities on the increased risk of COVID-19 breakthrough infections…
New research: Preeclampsia-related heart failure disproportionately impacts Black mothers
Among women with preeclampsia, new Truveta Research findings show that Black women are two times more likely to experience heart failure than white women. BELLEVUE, Wash.…
Truveta expands with three new US health system members
With 27 health system members, Truveta now includes de-identified patient journeys from all 50 US states. BELLEVUE, Wash. – January 24, 2023 – Three healthcare providers…
Truveta Research shares new insights on RSV hospitalization trends
New Truveta Research monitoring report shows rates of RSV hospitalizations compared to previous years, part of new research capabilities in Truveta Studio for ongoing disease monitoring.…
Truveta’s COVID-19 health equity research published in Frontiers in Public Health
New research published in Frontiers in Public Health shows racial disparities in COVID-19 hospitalization lengths of stay and access to treatments early in the pandemic. BELLEVUE,…